Concert Pharmaceuticals Inc is a United States-based company that is engaged in the pharmaceutical preparation and research industry. The Company is a clinical stage biotechnology company focused on applying the Company's DCE Platform (deuterated chemical entity platform) to create differentiated small molecule drugs. The Company tests and produces pharmaceutical drugs by utilizing the element deuterium. Its drug candidates address various therapeutic areas, including hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, schizophrenia, multiple tumors, and hyperparathyroidism.